Cubist Systematic Strategies, LLC Amarin Corp Plcuk Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.82 - $1.35 $41,562 - $68,426	50,686 New	50,686 $45,000
Q2 2023 Aug 14, 2023	BUY	$1.12 - $1.49 $6,928 - $9,217	6,186 Added 16.02%	44,812 $53,000
Q1 2023 May 15, 2023	SELL	$1.19 - $2.19 $198,876 - $365,999	-167,123 Reduced 81.23%	38,626 $57,000
Q4 2022 Feb 14, 2023	BUY	$1.07 - $1.34 $220,151 - $275,703	205,749 New	205,749 $248,000
Q2 2022 Aug 15, 2022	SELL	$1.13 - $3.69 $25,018 - $81,696	-22,140 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.85 - $3.73 $311,658 - $407,890	-109,354 Reduced 83.16%	22,140 $73,000
Q4 2021 Feb 14, 2022	BUY	$3.24 - $5.18 $277,674 - $443,936	85,702 Added 187.15%	131,494 $443,000
Q3 2021 Nov 15, 2021	BUY	$3.94 - $5.84 $41,645 - $61,728	10,570 Added 30.01%	45,792 $234,000
Q2 2021 Aug 16, 2021	SELL	$4.26 - $6.5 $1.39 Million - $2.12 Million	-325,811 Reduced 90.24%	35,222 $154,000
Q1 2021 May 17, 2021	BUY	$5.03 - $8.8 $271,011 - $474,135	53,879 Added 17.54%	361,033 $2.24 Million
Q4 2020 Feb 16, 2021	BUY	$4.04 - $5.31 $1.22 Million - $1.61 Million	303,035 Added 7357.0%	307,154 $1.5 Million
Q3 2020 Nov 16, 2020	SELL	$3.64 - $7.76 $1.71 Million - $3.64 Million	-468,779 Reduced 99.13%	4,119 $17,000
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $1.91 Million - $3.3 Million	399,196 Added 541.64%	472,898 $3.27 Million
Q1 2020 May 15, 2020	BUY	$4.0 - $21.53 $293,448 - $1.58 Million	73,362 Added 21577.06%	73,702 $295,000
Q4 2019 Feb 14, 2020	BUY	$13.94 - $24.12 $4,739 - $8,200	340 New	340 $7,000
Q3 2019 Nov 14, 2019	SELL	$13.89 - $23.16 $924,629 - $1.54 Million	-66,568 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$16.27 - $20.51 $979,681 - $1.23 Million	60,214 Added 947.66%	66,568 $1.29 Million
Q1 2019 May 15, 2019	SELL	$12.61 - $22.33 $185,657 - $328,764	-14,723 Reduced 69.85%	6,354 $132,000
Q4 2018 Feb 14, 2019	BUY	$12.41 - $22.98 $261,565 - $484,349	21,077 New	21,077 $287,000
Q3 2018 Nov 14, 2018	SELL	$2.45 - $16.27 $45,966 - $305,257	-18,762 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$2.68 - $3.48 $9,334 - $12,120	-3,483 Reduced 15.66%	18,762 $58,000
Q1 2018 May 15, 2018	BUY	$2.99 - $4.44 $33,320 - $49,479	11,144 Added 100.39%	22,245 $67,000
Q4 2017 Feb 14, 2018	SELL	$3.06 - $4.09 $163,737 - $218,851	-53,509 Reduced 82.82%	11,101 $45,000
Q3 2017 Nov 14, 2017	BUY	$3.03 - $3.72 $195,768 - $240,349	64,610	64,610 $226,000

Others Institutions Holding AMRN

# of Institutions

177

Shares Held

65.1M

Call Options Held

258K

Put Options Held

98K

Sarissa Capital Management LP Greenwich, CT

24.9M
Shares

$10.9 Million
3.89% of portfolio
Kynam Capital Management, LP Princeton, NJ

12.4M
Shares

$5.46 Million
0.64% of portfolio
Eversept Partners, LP New York, NY

3.31M
Shares

$1.46 Million
0.16% of portfolio
Morgan Stanley New York, NY

2.55M
Shares

$1.12 Million
0.0% of portfolio
Scp Investment, LP

2.5M
Shares

$1.1 Million
1.16% of portfolio

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $177M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account